The Bottom Line

Vaginal dryness and vulvar skin changes affect up to 50% of postmenopausal women as part of a condition now called genitourinary syndrome of menopause (GSM). Unlike hot flashes, GSM does not improve on its own over time — it progressively worsens without treatment. Effective treatments range from vaginal moisturizers and lubricants to low-dose vaginal estrogen, which is safe for most women and significantly improves symptoms.

What Happens to Vulvovaginal Skin During Menopause

Estrogen maintains the health of vulvar and vaginal tissues. When estrogen declines during menopause:

  • Vaginal epithelium thins: From 20-40 cell layers to just a few, making tissue fragile and prone to tears
  • Decreased lubrication: Blood flow to vaginal tissue decreases and moisture-producing glands become less active
  • pH changes: Vaginal pH rises from 3.5-4.5 (acidic, protective) to 6-7.5 (neutral), increasing susceptibility to infections
  • Loss of elasticity: Vaginal tissue becomes less flexible, which can cause discomfort
  • Vulvar skin changes: The labia thin and lose fat padding, skin becomes more delicate and easily irritated
  • Urinary symptoms: Thinning of urethral tissue can cause urgency, frequency, and recurrent UTIs

Symptoms of GSM

  • Vaginal dryness and lack of lubrication
  • Burning, itching, or irritation of the vulva
  • Pain during intercourse (dyspareunia) — reported by up to 45% of postmenopausal women
  • Light bleeding after intercourse (from fragile tissue)
  • Recurrent urinary tract infections
  • Urinary urgency and frequency
  • Vulvar skin that appears pale, thin, or shiny

Treatment Options

First-line: non-hormonal moisturizers and lubricants

  • Vaginal moisturizers: Applied 2-3 times weekly regardless of sexual activity. Products like Replens or Hyalo GYN provide longer-lasting hydration than lubricants. Look for hyaluronic acid-based formulas.
  • Lubricants: Used during sexual activity. Water-based or silicone-based lubricants reduce friction. Avoid products with glycerin (can promote yeast infections), fragrances, or warming agents.
  • Coconut oil: An effective natural lubricant, but not compatible with latex condoms (breaks down latex).

Second-line: low-dose vaginal estrogen

  • Vaginal estradiol cream (Estrace): Applied 2-3 times weekly. Restores vaginal tissue to premenopausal quality.
  • Vaginal estradiol tablet (Vagifem/Yuvafem): Small tablet inserted 2x weekly. Convenient and precisely dosed.
  • Vaginal estradiol ring (Estring): Inserted every 3 months. Provides steady, low-dose estrogen delivery.
  • Safety: Low-dose vaginal estrogen produces minimal systemic absorption. The North American Menopause Society considers it safe for most women, including many breast cancer survivors (discuss with your oncologist).

Other options:

  • Ospemifene (Osphena): Oral SERM (selective estrogen receptor modulator) that treats vaginal dryness without being estrogen. Daily pill.
  • Prasterone (Intrarosa): Vaginal DHEA insert used nightly. Converted to estrogen and testosterone locally.
  • Laser therapy (MonaLisa Touch, FemiLift): Fractional CO2 laser applied vaginally to stimulate collagen and restore tissue. Promising but long-term evidence is still accumulating. Not yet endorsed by all professional societies.

Vulvar Skin Care Tips

  • Wash with warm water only or a gentle, fragrance-free cleanser (avoid soap on vulvar tissue)
  • Avoid douching — disrupts protective vaginal flora
  • Wear cotton underwear; avoid tight synthetic fabrics
  • Apply a thin layer of petroleum jelly to the vulva after bathing for barrier protection
  • Avoid perfumed products, wipes, and panty liners with fragrances in the vulvar area

Frequently Asked Questions

Will vaginal dryness go away on its own?

No. Unlike hot flashes, which tend to diminish over time, GSM is progressive — it gets worse without treatment. Vaginal tissue continues to thin and symptoms worsen over the years. Treatment at any point can significantly improve symptoms, but earlier intervention prevents more severe changes.

Is vaginal estrogen safe after breast cancer?

This depends on your cancer type and treatment. Low-dose vaginal estrogen produces very low systemic absorption and is considered safe for many breast cancer survivors by NAMS and ACOG. However, some oncologists prefer non-hormonal options. Always discuss with your oncology team.

I'm embarrassed to discuss this — is that normal?

Absolutely. Studies show that only 25% of symptomatic women discuss GSM with their healthcare provider, and only 7% receive treatment. Yet GSM significantly impacts quality of life. Healthcare providers discuss these issues routinely — there is nothing to be embarrassed about, and effective treatment is available.

  1. Portman DJ, Gass ML. "Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society." Menopause. 2014;21(10):1063-1068.
  2. NAMS 2020 GSM Position Statement. "The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society." Menopause. 2020;27(9):976-992.
  3. Lethaby A, et al. "Local oestrogen for vaginal atrophy in postmenopausal women." Cochrane Database of Systematic Reviews. 2016;8:CD001500.